Report overview
This report aims to provide a comprehensive presentation of the global market for Home Insulin Delivery (Dosing) Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Home Insulin Delivery (Dosing) Devices. This report contains market size and forecasts of Home Insulin Delivery (Dosing) Devices in global, including the following market information:
Global Home Insulin Delivery (Dosing) Devices Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Home Insulin Delivery (Dosing) Devices Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Home Insulin Delivery (Dosing) Devices companies in 2022 (%)
The global Home Insulin Delivery (Dosing) Devices market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Insulin Pens Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Home Insulin Delivery (Dosing) Devices include Tandem Diabetes Care, Biocon, Roche Holding AG, Insulet Corporation, B. Braun, BD, Eli Lilly and Company, Novo Nordisk and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Home Insulin Delivery (Dosing) Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Home Insulin Delivery (Dosing) Devices Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, by Type, 2022 (%)
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Global Home Insulin Delivery (Dosing) Devices Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, by Application, 2022 (%)
Hospitals Pharmacy
Online Pharmacy
Retail Pharmacy
Global Home Insulin Delivery (Dosing) Devices Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Home Insulin Delivery (Dosing) Devices revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Home Insulin Delivery (Dosing) Devices revenues share in global market, 2022 (%)
Key companies Home Insulin Delivery (Dosing) Devices sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Home Insulin Delivery (Dosing) Devices sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tandem Diabetes Care
Biocon
Roche Holding AG
Insulet Corporation
B. Braun
BD
Eli Lilly and Company
Novo Nordisk
Sanofi
Wockhardt
Ypsomed Holding
Medtronic
Julphar
Beta Bionics
Copernicus
Dance Biopharm
Debiotech
MannKind
Owen Mumford
SOOIL
Valeritas
West Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Home Insulin Delivery (Dosing) Devices, market overview.
Chapter 2: Global Home Insulin Delivery (Dosing) Devices market size in revenue and volume.
Chapter 3: Detailed analysis of Home Insulin Delivery (Dosing) Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Home Insulin Delivery (Dosing) Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Home Insulin Delivery (Dosing) Devices capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
